Brown, Elizabeth
Bullock, Alex
2019-02-28
<p>Report outlining how genomic DNA was extracted from patient derived diffuse intrinsic pontine glioma cell lines*, PCR was used to amplify commonly mutated exons of ACVR1, and the regions Sanger sequenced.</p>
<p>* Lines HSJD-GBM-002, SU-DIPG-IV, HSJD-DIPG-006, HSJD-DIPG-007, HSJD-DIPG-011, SU-DIPG-XXI</p>
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
https://doi.org/10.5281/zenodo.2579809
oai:zenodo.org:2579809
Zenodo
https://zenodo.org/communities/sgc-opennotebook
https://zenodo.org/communities/openlabnotebooks
https://doi.org/10.5281/zenodo.2579808
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
dipg
diffuse intrinsic pontine glioma
pcr
sanger sequencing
patient derived cell lines
genomic dna extraction
acvr1
alk2
Sequencing of ACVR1/ALK2 in patient derived DIPG cell lines
info:eu-repo/semantics/article